Clinical Trials Browser

Has results × Gliosarcoma × Sorafenib × Clear all

NCT00335764 2018-07-02

Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

Phase 1/2 Completed

92 enrolled 24 charts

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT00621686 2018-05-08

Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme

Phase 2 Completed

54 enrolled 8 charts

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00597493 2013-06-24

Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM

Phase 2 Completed

32 enrolled 9 charts

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma